Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
NBSE....................https://stockcharts.com/h-sc/ui?s=NBSE&p=W&b=5&g=0&id=p86431144783
ohhh,this was a t s p,private pick from .67(over 100k followers) they usually are flippable for couple days or until his next pic starts running lol
next res. sma200@ 1.34,blue sky above that,only old highs res. 1.51,3.16,4.44
(NASDAQ: NBSE) shares surged 14.5% to $0.86 in pre-market trading. Neubase Therapeutics, on Feb. 22, said board determined for company to dissolve, liquidate and distribute to stockholders its available assets.
shares to short,from 250k to 30k today,8k,if ZERO BORROW might run up
holding yesterdays gains is a bullish signal IMHO
i have said, all along, that shorting should be illegal. allows for all kinds of manipulation.
Strategic initiatives is the name of the game, once merger is announced $5.00 is written all over it. No chasing, you chase the stock will get shorted back.
ended at 1.15 eod a/h.
Oh ok lol. Yea I agree :)
HOS close today would be awesome!
mr. trip is here too!,,,
Hope so it’s been slow
Look at this gail. === As of November 06, 2023, 3,729,206 shares of the common stock, par value $0.0001, of the registrant were outstanding.
$2 after market close???
lets do this!
YES!!!!!!!!!!!!!!!!!!!!!!!
yup, i sure am!
yup, i sure am!
Hey Gail. Are you in this one? I took some $1.05's
Looks excellent dino!
It was inevitable.
he dino, quiet board here. it …….
….
appears i was in this some time back but i hopped back in today, so, hi…. to you.
Crazy trading going on today... hmmmmm
strong late night buying, lets do this!
Yet beginning three days later Symetryx sold all its shares of NBSE.
It seems Symetryx and the Neubase Board were unable to find or see eye to eye on a suitable merger candidate. Or something else that promoted a large active investor to sell its entire position.
Symetryx exits stake in NeuBase Therapeutics, shares fall
Sep. 19, 2023 2:03 PM ET
NeuBase Therapeutics, Inc. (NBSE)
By: Deepa Sarvaiya, SA News Editor
NeuBase Therapeutics (NASDAQ:NBSE) falls 14% after disclosing that Symetryx has sold its entire position in the biopharmaceutical company.
Symetryx sold 203,337 shares in the price range of $1.19-$1.44. Symetryx has sold 680,081 shares in the last 10 days.
According to the form 4 [Sept. 14th, 2023], Symetryx now beneficially owns no shares in the company.
As per the recent filing on Sept. 06, Symetryx acquired 20% stake in NeuBase.
https://seekingalpha.com/filing/7872032?hasComeFromMpArticle=false
Is today's higher action a bounce, or a facilitated bounce, or something real?
.
Hopefully. And the overall market is curling. I work all the time so I can’t keep up with it :(
looks like the investors meeting went well i guess.
yup, lots of buys hitting now.
Here it goes
they were saying, over on stock twits, that there is a shareholder meeting tomorrow and news of some sort is rumored. thats all i know.
Never know when news hits. Could run like vistagen . Fingers crossed.
Followers
|
8
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
249
|
Created
|
08/21/19
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |